Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Amneal Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were -70.8M, a 35.21% decrease year-over-year.
- Amneal Pharmaceuticals Inc. shareholder equity for 2025 were -70.8M, a 35.21% decrease from 2024.
- Amneal Pharmaceuticals Inc. shareholder equity for 2024 were -109.3M, a 652.38% decrease from 2023.
- Amneal Pharmaceuticals Inc. shareholder equity for 2023 were 19.8M, a 93.37% decrease from 2022.
- Amneal Pharmaceuticals Inc. shareholder equity for 2022 were 298.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Amneal Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-71 |
| 2024 | $-109 |
| 2023 | $20 |
| 2022 | $298 |
| 2021 | $360 |
| 2020 | $303 |
| 2019 | $232 |
| 2018 | $505 |
| Amneal Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-71 |
| 2024-12-31 | $-109 |
| 2023-12-31 | $20 |
| 2022-12-31 | $298 |
| 2021-12-31 | $360 |
| 2020-12-31 | $303 |
| 2019-12-31 | $232 |
| 2018-12-31 | $505 |
Amneal Pharmaceuticals Inc. Shareholder Equity — FAQ
Amneal Pharmaceuticals Inc. (AMRX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMRX's shareholder equity history?
The chart and table above show Amneal Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.